Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: March 11, 2024
Reporting Period: This filing reports on events occurring on March 11, 2024, specifically regarding upcoming investor presentations.
Financial Metrics
This Form 8-K does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing serves solely to disclose the intent to use specific presentation materials for investor communications.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing references an Investor Presentation dated March 2024 (Exhibit 99.1) which contains the substantive business updates, but the text of that presentation is not included in this filing.
Guidance, Outlook, and Risks
Management Commentary: Executive officers have scheduled upcoming presentations for investors and analysts. They intend to use the material filed as Exhibit 99.2 for these presentations.
Regulatory Note: The information in Item 7.01 and Exhibit 99.2 is furnished pursuant to Regulation FD and is not deemed "filed" under Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Investor Presentation dated March 2024) for actual financial guidance and operational updates, as this 8-K only announces the presentation.
- Confirm the trading symbol KIDS on the Nasdaq Global Market.
- Note that the information provided in this specific filing is not legally "filed" for liability purposes under Section 18 of the Exchange Act.